Longevity Health Holdings, Inc. Warrant
XAGEW
XAGEW was delisted on the 11th of September, 2025.
14 hedge funds and large institutions have $115K invested in Longevity Health Holdings, Inc. Warrant in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 2 closing their positions.
0.32% less ownership
Funds ownership: 9.72% → 9.4% (-0.32%)
13% less funds holding
Funds holding: 16 → 14 (-2)
33% less capital invested
Capital invested by funds: $172K → $115K (-$56.4K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.67K |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$1.13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$517 |
| 4 |
Walleye Capital
New York
|
-$327 |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$320 |
XAGEW Hedge Fund Activity: Q4 2024 in Review
14 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Warrant (XAGEW) for Q4 2024, worth a combined $115K — down 33% from $172K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of XAGEW and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, cutting an estimated $1.67K.
- 14 institutional investors held Longevity Health Holdings, Inc. Warrant (XAGEW) as of Q4 2024, down from 16 in Q3 2024.
- Funds reported $115K of Longevity Health Holdings, Inc. Warrant stock for Q4 2024, down 33% quarter-over-quarter.
- 0 funds opened new Longevity Health Holdings, Inc. Warrant positions in Q4 2024 and 2 closed out, a net change of -2 holders.
- The largest Longevity Health Holdings, Inc. Warrant seller in Q4 2024 was Citadel Advisors, an estimated $1.67K sold.
Based on aggregated 13F filings for Q4 2024.